These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia. McEvoy JP; McCue M; Freter S Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223 [TBL] [Abstract][Full Text] [Related]
6. d-Amphetamine: effects on memory in a depressed population. Reus VI; Silberman E; Post RM; Weingartner H Biol Psychiatry; 1979 Apr; 14(2):345-56. PubMed ID: 476223 [TBL] [Abstract][Full Text] [Related]
7. Low-level serum anticholinergicity as a source of baseline cognitive heterogeneity in geriatric depressed patients. Nebes RD; Pollock BG; Mulsant BH; Kirshner MA; Halligan E; Zmuda M; Reynolds CF Psychopharmacol Bull; 1997; 33(4):715-20. PubMed ID: 9493484 [TBL] [Abstract][Full Text] [Related]
8. Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline. Richardson JS; Keegan DL; Bowen RC; Blackshaw SL; Cebrian-Perez S; Dayal N; Saleh S; Shrikhande S Int Clin Psychopharmacol; 1994; 9(1):35-40. PubMed ID: 8195581 [TBL] [Abstract][Full Text] [Related]
9. Antidepressant effect on memory in depressed older persons. Marcopulos BA; Graves RE J Clin Exp Neuropsychol; 1990 Oct; 12(5):655-63. PubMed ID: 2258429 [TBL] [Abstract][Full Text] [Related]
10. Anticholinergic drugs and physical function among frail elderly population. Landi F; Russo A; Liperoti R; Cesari M; Barillaro C; Pahor M; Bernabei R; Onder G Clin Pharmacol Ther; 2007 Feb; 81(2):235-41. PubMed ID: 17192773 [TBL] [Abstract][Full Text] [Related]
11. [Deficits in memory retrieval: an argument in favor of frontal subcortical dysfunction in depression]. Fossati P; Deweer B; Raoux N; Allilaire JF Encephale; 1995; 21(4):295-305. PubMed ID: 7588169 [TBL] [Abstract][Full Text] [Related]
12. Memory deficits and anticholinergic levels in chronic schizophrenia. Perlick D; Stastny P; Katz I; Mayer M; Mattis S Am J Psychiatry; 1986 Feb; 143(2):230-2. PubMed ID: 3946662 [TBL] [Abstract][Full Text] [Related]
13. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685 [TBL] [Abstract][Full Text] [Related]
14. [Antidepressive agents and memory]. Danion JM Encephale; 1993 Jul; 19 Spec No 2():417-22. PubMed ID: 8281908 [TBL] [Abstract][Full Text] [Related]
15. Perospirone in the treatment of schizophrenia: effect on verbal memory organization. Araki T; Yamasue H; Sumiyoshi T; Kuwabara H; Suga M; Iwanami A; Kato N; Kasai K Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):204-8. PubMed ID: 16300872 [TBL] [Abstract][Full Text] [Related]
16. Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia. Mori K; Nagao M; Yamashita H; Morinobu S; Yamawaki S Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):659-65. PubMed ID: 15276691 [TBL] [Abstract][Full Text] [Related]
18. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta. Sumiyoshi T; Higuchi Y; Itoh T; Matsui M; Arai H; Suzuki M; Kurachi M; Sumiyoshi C; Kawasaki Y Psychiatry Res; 2009 Jun; 172(3):180-3. PubMed ID: 19386475 [TBL] [Abstract][Full Text] [Related]
19. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Houthoofd SA; Morrens M; Sabbe BG Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365 [TBL] [Abstract][Full Text] [Related]
20. Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients. Mori K; Yamashita H; Nagao M; Horiguchi J; Yamawaki S Pharmacopsychiatry; 2002 Jan; 35(1):6-11. PubMed ID: 11819152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]